Financials
- Market Capitalization 2.22 B
- Employee 835
- Founded 1980
- CEO Douglas S. Ingram
- Website www.sarepta.com
- Headquarter Delaware, United States
- FIGI BBG000BCJ161
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-6.2
市销率
0.99
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 1920 | MLYS Mineralys Therapeutics, Inc. - Common Stock | 25.67 USD | +0.27% | +0.79% | -0.50% | -36.41% | 2.27 B USD | ||
| 1921 | PHVS Pharvaris N.V. - Ordinary Shares | 34.61 USD | -2.01% | -7.26% | +6.72% | +60.98% | 2.26 B USD | ||
| 1946 | MESO Mesoblast Limited - American Depositary Shares | 16.76 USD | -3.90% | -0.36% | +18.70% | +28.43% | 2.17 B USD | ||
| 1953 | AUPH Aurinia Pharmaceuticals Inc - Common Shares | 16.11 USD | -1.10% | -2.95% | +9.44% | +35.04% | 2.14 B USD |